In its second-quarter 2026 investor letter, Jensen Quality Growth Equity Strategy highlighted Abbott Laboratories (NYSE:ABT). On July 24, 2026, Abbott Laboratories (NYSE:ABT) closed at $103.06 per share. One-month return of Abbott Laboratories (NYSE:ABT) was 7.04%, and its shares lost 18.43% over the past 52 weeks. Abbott Laboratories (NYSE:ABT) has a market capitalization of about $179.51 billion, with a 52-week trading range between $81.97 - $137.49. Jensen Quality Growth Equity Strategy stated the following regarding Abbott Laboratories (NYSE:ABT) in its Q2 2026 investor letter: